A R Azzouzi
Overview
Explore the profile of A R Azzouzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
229
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maulaz P, Malinge M, Farges D, Ingster O, Azzouzi A, Bigot P
Prog Urol
. 2020 Jul;
30(10):500-506.
PMID: 32718886
Introduction: Bourneville's tuberous sclerosis or Tuberous Sclerosis Complex (TSC) is an autosomal dominant hereditary phakomatosis associated with angiomyolipomas (AML) of the kidney. The aim of this study was to identify...
2.
Segalen T, Lebdai S, Panayotopoulos P, Culty T, Brassart E, Riou J, et al.
Prog Urol
. 2019 Sep;
29(12):589-595.
PMID: 31506249
Objectives: During ureteroscopy for urolithiasis, postoperative ureteral drainage with double J stent is frequently used. It may reduce acute postoperative pain and late ureteral stenosis. Double J stent can have...
3.
Rodriguez-Rivera J, Rodriguez-Lay R, Zegarra-Montes L, Benzaghou F, Gaillac B, Azzouzi A, et al.
Actas Urol Esp (Engl Ed)
. 2018 Apr;
42(10):632-638.
PMID: 29699883
Objectives: To explore the proportion of patients with higher risk localized prostate cancer (PCa) that would become safely biopsy negative 12 months after non-thermal focal therapy with padeliporfin vascular-targeted photodynamic...
4.
Noweski A, Roosen A, Lebdai S, Barret E, Emberton M, Benzaghou F, et al.
Eur Urol Focus
. 2018 Apr;
5(6):1022-1028.
PMID: 29661587
Background And Objective: To assess the medium-term tumor control in patients with localized prostate cancer (PCa) treated with vascular-targeted photodynamic (VTP) therapy with TOOKAD Soluble WST11 (VTP) and to assess...
5.
Gardic S, Misrai V, Azzouzi A, Campeggi A, Cornu J, de la Taille A, et al.
Prog Urol
. 2017 Jun;
27(10):559-563.
PMID: 28651993
Objective: To evaluate bleeding risk in patients on anticoagulation for mechanical cardiac valve operated for benign prostatic obstruction (BPO). Material And Method: Fifty-eight patients operated between 1998 and 2014, in...
6.
Mathieu R, Lebdai S, Cornu J, Benchikh A, Azzouzi A, Delongchamps N, et al.
Prog Urol
. 2017 May;
27(6):362-368.
PMID: 28495071
Purpose: To evaluate perioperative cost related to surgical treatments of benign prostatic obstruction (BPO): photoselective vaporization of the prostate (pvp), holmium/thullium laser enucleation (HoLEP/ThuLEP), transurethral resection of the prostate (TURP)...
7.
Postema A, de Reijke T, Ukimura O, van den Bos W, Azzouzi A, Barret E, et al.
World J Urol
. 2016 Feb;
34(10):1373-82.
PMID: 26892160
Purpose: To reach standardized terminology in focal therapy (FT) for prostate cancer (PCa). Methods: A four-stage modified Delphi consensus project was undertaken among a panel of international experts in the...
8.
Lebdai S, Azzouzi A, Delongchamps N, Benchikh A, Campeggi A, Cornu J, et al.
Prog Urol
. 2015 Dec;
26(2):129-36.
PMID: 26643518
Introduction: The medicoeconomic issues of drug management of benign prostatic hyperplasia (BPH) are essential due to the aging population and the increasing number of therapeutic options. It is thus essential...
9.
Bigot P, Lebdai S, Azzouzi A
Prog Urol
. 2015 Oct;
25(16):1169-70.
PMID: 26455777
No abstract available.
10.
Misrai V, Barry Delongchamps N, Lebdai S, Azzouzi A, Benchikh A, Cornu J, et al.
Prog Urol
. 2015 Jul;
25(10):583-9.
PMID: 26159052
Purpose: Rare and severe complications of benign prostatic hyperplasia (BPH) surgery are poorly documented in the literature. Our purpose was to make an inventory of severe and unexpected complications of...